Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of GAS2 mRNA | increases expression | 19933214
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of GAS2 mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of GAS2 mRNA | increases expression | 11264010
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of GAS2 protein | affects expression | 20106945
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of GAS2 mRNA | increases expression | 14729362
|
D003042 |
Cocaine |
Cocaine affects the expression of GAS2 mRNA | affects expression | 15681117
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in increased expression of GAS2 protein | increases expression | 17475930
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of GAS2 mRNA | decreases expression | 20106945
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of GAS2 mRNA | affects cotreatment|decreases expression | 16054899
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of GAS2 mRNA | increases expression | 18042831
|
D004642 |
Emodin |
Emodin results in increased expression of GAS2 mRNA | increases expression | 16045814
|
D004958 |
Estradiol |
Estradiol results in decreased expression of GAS2 mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of GAS2 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAS2 mRNA | affects cotreatment|increases expression | 17942748
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of GAS2 mRNA | affects cotreatment|decreases expression | 16054899
|
C002950 |
methylformamide |
methylformamide analog results in decreased expression of GAS2 mRNA | decreases expression | 17040096
|
C002950 |
methylformamide |
methylformamide results in decreased expression of GAS2 mRNA | decreases expression | 17040096
|
C041786 |
palm oil |
palm oil results in increased expression of GAS2 mRNA | increases expression | 18042831
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of GAS2 mRNA] | affects reaction|decreases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of GAS2 mRNA | decreases expression | 19482888
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GAS2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of GAS2 mRNA | decreases expression | 18445702
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of GAS2 mRNA | increases expression | 16221962
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of GAS2 mRNA | affects cotreatment|decreases expression | 16054899
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GAS2 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of GAS2 mRNA | affects binding|decreases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAS2 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GAS2 mRNA | increases expression | 19933214
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of GAS2 mRNA | decreases expression | 17951470
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of GAS2 mRNA | increases expression | 17127020
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of GAS2 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
13.44 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
13.44 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
13.44 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.81 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.81 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.99 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.11 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.11 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
16.53 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
16.53 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
16.53 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.82 | 19621015 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.10 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.83 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.71 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.47 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
16.31 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
16.31 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
16.31 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
7.11 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.11 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 18985861 18177632 18316065 17157402 17507914 18775368 18558336 18940202 20603192 19460635 15238991 19232924 17688650 18396377 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.01 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.37 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.74 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.74 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
1.95 | 17388661 18323546 11325840 15136595 18234424 17020986 12006526 16978400 15093573 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.95 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.95 | 17261762 17289903 16675129 12948864 14630087 18497071 19861407 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.95 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.33 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.69 | 16835633 |
MESH:D003528 |
Carcinoma, Adenoid Cystic |
marker/mechanism |
|
| 16762588 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.65 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
8.65 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
8.65 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.65 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
8.65 | 20007298 1701930 20935162 17173139 6705139 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.76 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.48 | 16201981 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.30 | 18850075 16120746 18670907 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.51 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.27 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.27 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.12 | 4080065 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.66 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.78 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.78 | 16919318 17333356 17681005 11677210 16105132 17110522 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.78 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.05 | 15668235 8697196 12621046 16354765 15340226 |
MESH:D019970 |
Cocaine-Related Disorders |
|
Cocaine |
5.58 | 19606084 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
2.47 | 15824018 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
3.74 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.74 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.74 | 8888407 16575769 17688650 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.86 | 18372110 10498854 18093676 15276878 15643279 16614059 12913760 12388444 16413132 16651033 18433785 17979934 18483878 17010015 10700343 16989017 18295254 11948286 18710439 12161096 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.28 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.37 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.19 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.96 | 11751995 10990075 15331540 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.18 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
4.39 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.39 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.30 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.57 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
5.91 | 17906064 11529661 16781746 12392966 11421492 16109766 17522070 14550746 14725611 11743745 15968718 18713872 19085960 19923254 12705907 17562736 16177239 11739529 10915739 12594235 14986274 10663392 18071297 19164858 16081117 19370779 11287661 19420014 16227642 16485898 12958197 2444490 11834606 15619225 19739265 10774834 12540782 16393943 12153990 19416960 11461765 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.91 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
5.91 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.97 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.66 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.36 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
10.02 | 1851702 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
10.02 | 1851702 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.33 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
15.48 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
15.48 | 12083418 |
MESH:D004487 |
Edema |
|
rosiglitazone |
15.48 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
15.48 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.77 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.06 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.90 | 19148513 11473722 18566989 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.91 | 10568697 9294722 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.09 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
10.36 | 3659116 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
10.36 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
9.54 | 3922381 11558140 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
9.54 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
6.44 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
6.44 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
8.49 | 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
8.49 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
10.87 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
10.87 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
10.04 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
10.04 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
29.16 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
29.16 | 17967931 19551842 19004024 18296743 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
29.16 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
29.16 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
29.16 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
29.16 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.33 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.76 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.00 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
20.13 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
20.13 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Emodin |
20.13 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
20.13 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.55 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.09 | 8708960 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.38 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.47 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.90 | 15172196 11014644 16376943 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.26 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.46 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.29 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.16 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.21 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.40 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
13.63 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.63 | 19772884 16221962 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.63 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.03 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.90 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.67 | 16135485 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.62 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.74 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.54 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
7.54 | 12083418 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.47 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.07 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.49 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.30 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
8.30 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.30 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.68 | 16945680 16569931 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.31 | 18306037 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.20 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.34 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
6.58 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.58 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
11.45 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
11.45 | 20412841 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
11.45 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.45 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
16.96 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
16.96 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
16.96 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
16.96 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.31 | 18306037 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.31 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.54 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.54 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.54 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.92 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.92 | 15610895 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.43 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.44 | 17658394 17802794 18172266 17296974 17008537 18587576 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Emodin |
4.90 | 17077332 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.99 | 10373061 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.13 | 16294345 17596541 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.83 | 10052129 11830472 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.42 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.42 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
8.54 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Emodin |
8.54 | 15288473 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.54 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
8.54 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
8.54 | 15980055 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.54 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.82 | 19784758 11587558 19460945 16611625 12969438 12587719 19014921 16610002 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
3.82 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.12 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
10.27 | 2125692 18177683 9163691 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
10.27 | 8742319 19812893 21047994 19482888 19073162 15975961 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.27 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.27 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
9.35 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
9.35 | 18308698 17172636 2563599 1399818 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.35 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.13 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.37 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
3.37 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.37 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
3.74 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.47 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.06 | 11911406 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.97 | 11807958 17203775 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
5.97 | 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.35 | 19453300 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
10.40 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
10.40 | 16388313 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.27 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.66 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.10 | 18803445 18765137 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.41 | 15867202 16118317 15744524 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.38 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.91 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
7.32 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.32 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Cocaine |
5.91 | 18072171 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.91 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.91 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.91 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.91 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.34 | 17484760 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
4.96 | 18854779 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.96 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.60 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.17 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.04 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.04 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.04 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.57 | 8761367 16115947 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.76 | 18514411 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.76 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.20 | 8291058 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.32 | 20132043 16723640 19632207 18457598 20518802 17217161 11836018 21332399 18674790 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.32 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.58 | 16517039 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.23 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.18 | 19401270 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.50 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
6.50 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
5.39 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.39 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.56 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.12 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.43 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.60 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.60 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
7.57 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
7.57 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.03 | 11118676 11896295 11222880 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.03 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.76 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.51 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.51 | 16740699 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.18 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
11.76 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
11.76 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.18 | 16882103 |
MESH:D011618 |
Psychotic Disorders |
|
Cocaine |
4.73 | 16134406 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.23 | 16636934 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.32 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
3.89 | 11700416 18379247 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.05 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
marker/mechanism |
|
| 16762588 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.05 | 19110320 15737665 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.70 | 16636934 |
MESH:D012640 |
Seizures |
|
Cocaine |
9.52 | 10454489 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
9.52 | 3137016 16876388 4039156 11442880 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
9.52 | 3137016 17978042 14763951 16876388 1511512 15475178 11044598 11738929 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.69 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.39 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.39 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.81 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.38 | 16517039 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.68 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.41 | 12833885 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.19 | 15472012 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.37 | 15138204 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.93 | 12837982 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.50 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.04 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.77 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
2.95 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.56 | 19048282 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.10 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.39 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
3.09 | 14692829 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.51 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.85 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.17 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
11.34 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
11.34 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.47 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.42 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.12 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.62 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.31 | 17120751 |